Finance

Lists
600789:SHA
Shandong Lukang Pharmaceutical Co Ltd
CNÂ¥7.80
+2.23%
(+0.17) 1D
Sep 8, 3:00:04 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 600789...
Open
CNÂ¥7.61
High
CNÂ¥7.83
Low
CNÂ¥7.58
Mkt. cap
7.92B
Avg. vol.
27.79M
Volume
22.06M
Dividend
0.64%
Quarterly dividend
CNÂ¥0.01
Ex-dividend date
Jul 15, 2026
P/E ratio
54.37
52-wk high
CNÂ¥10.89
52-wk low
CNÂ¥6.48
EPS
CNÂ¥0.14
Shares outstanding
677.10M
No. of employees
6K
Open
CNÂ¥7.61
High
CNÂ¥7.83
Low
CNÂ¥7.58
Mkt. cap
7.92B
Avg. vol.
27.79M
Volume
22.06M
Dividend
0.64%
Quarterly dividend
CNÂ¥0.01
Ex-dividend date
Jul 15, 2026
P/E ratio
54.37
52-wk high
CNÂ¥10.89
52-wk low
CNÂ¥6.48
EPS
CNÂ¥0.14
Shares outstanding
677.10M
No. of employees
6K
About Shandong Lukang Pharmaceutical Co Ltd
CEO-
Employees6.47K
Founded1966
Headquarters-
SectorPharmaceutical industry
Websitelkpc.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
1.47B
1.14B
1.62B
1.62B
Cost of goods sold
1.13B
918.75M
1.27B
1.25B
Cost of revenue
1.13B
918.75M
1.27B
1.25B
Research and development expenses
82.71M
78.26M
64.32M
78.32M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
167.90M
202.59M
169.89M
173.82M
Operating expense
224.11M
308.76M
241.39M
240.28M
Total operating expenses
1.35B
1.23B
1.51B
1.49B
Operating income
115.74M
-85.74M
103.13M
133.22M
Other non operating income
9.51M
-6.76M
-11.08M
-42.80M
EBT including unusual items
43.40M
-25.13M
66.74M
89.18M
EBT excluding unusual items
104.27M
-105.95M
80.99M
101.48M
Income tax expense
7.43M
9.58M
10.20M
-275.03K
Effective tax rate
17.12%
-38.14%
15.29%
-0.31%
Other operating expenses
-23.55M
34.36M
-98.01K
-4.58M
Net income
34.36M
-28.89M
53.25M
84.89M
Net profit margin
2.34%
-2.53%
3.29%
5.24%
Earnings per share
-
-
-
-
Interest and investment income
2.22M
3.18M
2.44M
13.50M
Interest expense
-15.83M
-16.52M
-13.50M
-2.44M
Net interest expenses
-13.61M
-13.35M
-11.06M
11.06M
Depreciation and amortization charges
-
-
-
-
EBITDA
215.49M
21.61M
210.49M
243.51M
Gain or loss from assets sale
54.69K
-168.15K
-
-1.95K
AI content may include mistakes. Learn more
Google apps